BUSPIRONE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 21 adverse event reports in the FDA FAERS database where BUSPIRONE was used for Psoriasis.
Most Reported Side Effects for BUSPIRONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Completed suicide | 718 | 16.2% | 717 | 229 |
| Drug ineffective | 469 | 10.6% | 4 | 86 |
| Toxicity to various agents | 406 | 9.1% | 335 | 178 |
| Anxiety | 315 | 7.1% | 3 | 46 |
| Serotonin syndrome | 275 | 6.2% | 12 | 205 |
| Dizziness | 195 | 4.4% | 1 | 46 |
| Drug interaction | 195 | 4.4% | 14 | 104 |
| Nausea | 192 | 4.3% | 0 | 37 |
| Fatigue | 185 | 4.2% | 1 | 44 |
| Tremor | 185 | 4.2% | 0 | 63 |
| Drug hypersensitivity | 182 | 4.1% | 1 | 6 |
| Off label use | 179 | 4.0% | 1 | 74 |
| Drug abuse | 169 | 3.8% | 71 | 50 |
| Suicidal ideation | 169 | 3.8% | 19 | 61 |
| Headache | 165 | 3.7% | 1 | 34 |
Other Indications for BUSPIRONE
Product used for unknown indication (1,874)
Anxiety (709)
Depression (257)
Major depression (78)
Generalised anxiety disorder (58)
Suicide attempt (56)
Anxiety disorder (54)
Panic attack (53)
Psychotic disorder (38)
Bipolar disorder (30)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)